
Benzo Buddies is a free online peer forum for people who are tapering off a benzodiazepine or a z-drug, or who have already stopped and are still unwell. It has been running since 2004, and its boards are sorted by where a person is: still tapering, finished and still symptomatic, or well enough to write a success story. No physician runs it; its members are patients, former patients, and the people who live with them.
Why does a person with a doctor, a pharmacy, and a prescription go looking for strangers on a message board? Usually because the prescriber said the drug was safe, and then, when the symptoms started, said they could not be from the drug. The forum is where that person first hears another patient say that the same thing happened to them.
That sentence is worth a great deal, and it is where the trouble starts. A forum can validate, compare, and keep company. It cannot examine, prescribe, or take responsibility for a taper.
Physical dependence is the nervous system’s adaptation to a drug taken daily, as prescribed, so that lowering the dose produces withdrawal symptoms. Addiction is compulsive use that continues despite harm, and most people on a taper board have never taken more than they were told to.
In plain words, dependence is not addiction, and the 2020 United States Food and Drug Administration (FDA) boxed-warning update for the benzodiazepine class lists the two as separate risks. Physical dependence, the updated label says, can develop with steady use as prescribed, and stopping abruptly or cutting the dose quickly can bring on withdrawal reactions, some of them dangerous. The label’s answer is a gradual taper.
The wrong label sends a patient to the wrong kind of care. Addiction treatment facilities and support-group programs are built for compulsive use, and neither is medical care for a prescribed dependence. A person whose nervous system adapted to Klonopin (clonazepam) needs a physician who can bring the dose down slowly.
It does three things a physician’s office rarely has time for. It validates: a burning skin sensation that sounds impossible in an exam room turns out to be familiar to a dozen other members. It compares, so a person learns which symptoms are common in withdrawal and which deserve a separate medical look. And, it keeps company at three in the morning, when the office is closed and the symptom is loudest.
The forum also teaches a vocabulary. Interdose withdrawal, tolerance, windows and waves, cut and hold, the crossover taper to diazepam: these are patient words for real things, most of them described in the Ashton Manual, which is free to read at benzo.org.uk.
Members also help each other advocate. They tell a newcomer to bring the Ashton Manual to the appointment, to ask for a slower schedule rather than accept a fast one, and to look for a prescriber willing to work through a taper over months. For a person who has been dismissed twice, that is the most useful thing the forum does.
It runs out at the dose. A member’s taper schedule is a story about one nervous system, one drug, and one life, and it is not a prescription for anyone else. Copying it is like wearing another person’s glasses: the lenses are real, and they are still the wrong lenses.
Peer advice also has a selection problem. The people who are doing well leave the forum, and the people with the hardest courses stay and post the most, so a newcomer sees the worst cases over and over. Some threads amplify fear in a way a frightened nervous system does not need.
The forum knows this about itself, which is why members so often tell each other to check anything clinical with a physician who has experience with tapering. Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, draws the same line: the forum is for company and vocabulary, and a dose changes only between a patient and their physician.
Because withdrawal has no fixed length. Chapter III of the Ashton Manual says it is impossible to give an exact time for the duration of withdrawal symptoms, since so much depends on the person, the support, and the taper. With slow tapering, Professor C. Heather Ashton wrote, some long-term users have lost nearly all of their symptoms by the last tablet, and in most people symptoms fade within a few months.
The same chapter says symptoms characteristically wax and wane from day to day and week to week, and it calls the returns “wave-like recurrences.” Forum members call the good days windows and the bad stretches waves, and a member’s timeline is one person’s pattern, not a schedule anyone else is on. A post that reads “month four, still symptomatic” is one person’s month four, not a forecast.
Protracted symptoms frighten new members most. The Manual describes a minority of long-term users whose symptoms outlast the taper by a year or more, and the forum’s post-withdrawal board is where those members write. Their course is real, and the Manual also says it almost invariably continues to improve.
Rapid withdrawal, especially from a high-potency benzodiazepine, can precipitate a seizure, the Manual warns. A seizure or any symptom that feels like an emergency is a reason to call 911 or emergency services, not a reason to post.
Many people arrive at the forum after searching for “benzo detox.” The safe version of what they are looking for is not a detox in the facility sense: it is a gradual, medically supervised taper over months, sometimes longer, with the pace set by the patient’s symptoms rather than by a calendar. No facility stay and no fixed timeline belong in it.
Chapter II of the Ashton Manual gives the shape: reductions of up to one tenth of the current dose at each step, the next step only when the patient is ready, and, for a short-acting drug such as Xanax (alprazolam) or Ativan (lorazepam), a crossover taper to diazepam, whose long half-life gives a smooth fall in blood level.
The pace belongs to the patient, Professor Ashton wrote, and no doctor should impose a deadline. Dr. Leeds does not impose one.
The Maudsley Deprescribing Guidelines add the second half of the shape: the steps shrink as the dose falls, in proportion to what remains, because each milligram removed at a low dose takes away more effect at the receptor than the same milligram removed at a high dose. That is the hyperbolic taper. It is why the end of a taper is slower than the beginning, and why jumping from the last small dose is a decision, not a method.
Chapter II of the Manual allows one exception: triazolam (Halcion), a sleeping pill with a half-life of about two hours, which it says can be stopped without first switching to diazepam, and it applies the same reasoning to the z-drugs zolpidem and zaleplon. Dr. Leeds does not recommend stopping abruptly even there, and prefers a gradual taper, consistent with each drug’s own label. Abrupt stopping is never the plan in his practice, for any benzodiazepine or z-drug.
With limits, and with the physician in the loop. The limits are simple: read at set times of day rather than at night, since sleep is the first thing withdrawal takes; mute or leave the threads that frighten; and read the success stories board on purpose, because it is the board the people who got well come back to write on.
Anything clinical goes to the physician, not the thread. A new symptom, a dose that feels too high or too low, a question about switching drugs: a patient writes it down and brings it to the next visit, and if it cannot wait, calls.
Within Dr. Leeds’ practice the taper is a negotiation between two people; if a step is too hard, he slows it, and if the patient feels ready, they may agree to go a little faster, as tolerated. Informed consent belongs in that negotiation too: the risks first, the alternatives, including staying on the drug for now, the exit plan, and the right to decline or pause at any point. That is the conversation a forum cannot have.
A patient can have both. The forum gives them the words, the company, and the proof that other people came out the other side; the taper gives them a physician who has examined them and a dose that is theirs. Only one of them can write a prescription.
Dr. Leeds’ practice in Fort Lauderdale, Florida, offers one service: medically supervised benzodiazepine and z-drug tapering for patients in Florida, as a concierge practice rather than through insurance.
In Dr. Leeds’ practice the taper is gradual, patient-directed, and adapted to the person over months or longer, following the Ashton Manual crossover to diazepam where it helps and hyperbolic reductions as the dose falls. Contact Dr. Leeds to ask about a supervised taper.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact Us for expert guidance on safely tapering off benzodiazepines and reclaiming your life.





